Tesaro informs doctors of hypersensitivity risks with Varubi

Tesaro Inc. (NASDAQ:TSRO) issued a Dear Health Care Provider letter for Varubi rolapitant IV (SCH 619734)

Read the full 160 word article

User Sign In